Wild-type (WT) NOD.H-2h4 mice develop spontaneous autoimmune thyroiditis (SAT
All NOD.H-2h4 mice develop spontaneous autoimmune thyroiditis (SAT) when given NaI in their drinking water (1) (2) (3) . Thyroid infl ammation is chronic, with infi ltration of thyroids by lymphocytes, including CD4 + and CD8 + T cells, and B220 + B cells (3) (4) (5) (6) . All mice that develop SAT produce anti-mouse thyroglobulin (MTg)-specifi c autoantibodies, and IgG1 and IgG2b autoantibody levels generally correlate with SAT severity scores (1, 5) . We previously showed that B cell-defi cient NOD. H-2h4 mice did not develop SAT (5) . Although adult B cell-defi cient mice reconstituted with B cells or given passive anti-MTg autoantibodies did not develop SAT, T cells from B cell-defi cient mice could function as eff ector cells if B cells were provided during the maturation of T cells from bone marrow precursors (5) . These results suggested that B cells were required for the early activation of CD4 + T cells, functioning either as important APCs for activation of CD4 + eff ector T cells or to amplify responses of eff ector T cells so they could manifest their pathogenic potential. Because the defect in adult B cell-defi cient mice could not be corrected by reconstitution of B cells or anti-MTg autoantibodies (5), we hypothesized that CD4 + eff ector T cells initially activated in the absence of B cells might be rendered unresponsive so they were unable to induce SAT when B cells were provided to adults. Unresponsiveness of eff ector T cells could be due to induction of anergy or to preferential activation of regulatory T (T reg) cells when autoantigen is initially presented in the absence of B cells.
T cells specifi c for self-antigens not negatively selected in the thymus can be present in the periphery at birth (7) (8) (9) . In some strains of mice, nontolerant potentially autoreactive T cells can be activated and lead to spontaneous autoimmune disease. Activation of autoreactive T cells requires or is facilitated by B cells in several systems (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) . In most cases, activation of self-reactive lymphocytes in the periphery is prevented by naturally occurring T reg cells, a subset of thymus-derived CD4 + T cells that constitutively express CD25 (7) (8) (9) . Day 3 thymectomy (Tx) in mice that do not normally develop spontaneous autoimmune disease results in development of organ-specifi c autoimmune diseases, including thyroiditis due to elimination of CD4 + CD25 + T reg cells (21, 22) . B celldefi cient NOD.H-2h4 mice might not develop SAT if B cells are required for optimal activation of autoreactive T cells and if naturally occurring T reg cells are preferentially activated if B cells are not available to present autoantigen. This study was undertaken to test this hypothesis by asking if B cell-defi cient mice would develop SAT if CD25 + T reg cells were transiently eliminated.
RESULTS

CD25 + CD4 + T cells are not elevated in B cell-defi cient mice
To begin to determine if increases in peripheral CD4 + CD25 + T reg cells might explain the resistance of B cell-defi cient mice to SAT, percentages of CD4 + CD25 + T cells were compared in the spleens and peripheral blood of 4-and 8-wk-old B cell-defi cient and WT mice. Although there was some variation, the percentages of CD4 + CD25 + T cells were similar (averaging 10-15% of CD4 + T cells) for 4-8-wk-old WT and B cell-defi cient mice (Fig. 1, A and B ) not given NaI water as well as for older mice given NaI water for 8 wk (not depicted). Although most CD4 + CD25 + cells in B cell-defi cient mice could have been T reg cells, while some CD4 + CD25 + cells in WT mice could have been activated CD25 + eff ector T cells, the two populations could not be distinguished by CD25 expression. These results indicate that diff erences in absolute numbers of peripheral CD4 + CD25 + T cells in naive B cell-defi cient versus WT mice do not explain their diff erent susceptibility to SAT.
SAT develops in B cell-defi cient mice given anti-CD25 mAb B cell-defi cient NOD.H-2h4 mice given NaI water do not develop SAT, whereas all WT mice develop SAT and produce anti-MTg autoantibodies under the same conditions (Table I ). To determine if the inability of B cell-defi cient 
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mice to develop SAT might be due to CD4 + CD25 + T reg cells that suppressed the activation or function of eff ector T cells, B cell-defi cient mice were given three weekly injections of anti-CD25 mAb beginning at 10 d of age (23) . This resulted in depletion of most CD4 + CD25 + T cells 2-3 d after the last injection of mAb ( Fig. 1 E) . CD4 + CD25 + T cells gradually returned, and nearly normal numbers of CD4 + CD25 + splenic T cells were detected 7-10 d after the last antibody injection (Fig. 1 F) . B cell-defi cient mice given three weekly injections of anti-CD25 beginning at 10 d of age developed SAT, whereas B cell-defi cient mice given rat Ig did not develop SAT (Table I ). The SAT severity scores of anti-CD25-treated B cell-defi cient mice were comparable to those of rat Ig-treated WT NOD.H-2h4 mice (P > 0.6 for the experiment shown in Table I ). Thyroid lesions in both WT and B cell-defi cient mice predominantly had lymphocyte infi ltration (Fig. 2, A and B vs. D and E), but all lymphocytes in the thyroids of B cell-defi cient mice were T cells (Fig. 3 , D-F), whereas many B cells were also present in WT thyroids (Fig. 3 B) . WT mice given anti-CD25 beginning at 10 d of age consistently developed less severe SAT than controls (Table I, Fig. 1 C) were comparable to those of WT and B cell-defi cient mice (Fig. 1, A and B) . Very few CD8 + T cells in the spleens of NP Tg (Fig. 1 D) , WT, or B cell-defi cient mice (not depicted) expressed CD25. Tg mice, like B cell-defi cient mice, developed no or very mild SAT after receiving NaI water (Table II) , produced no detectable serum anti-MTg autoantibodies (Table II) , and were serum Ig negative (not depicted). However, NP Tg mice developed severe SAT (P < 10 −9 compared with controls), but no detectable anti-MTg autoantibodies, after being given anti-CD25 to transiently deplete T reg cells. Treatment of NP Tg mice with another rat anti-mouse mAb, i.e., anti-IL-10 (Table II) , using the injection schedule used for anti-CD25 had no eff ect on SAT. Thyroid lesions in anti-CD25-treated NP Tg mice were histologically like those in WT mice, although severity scores were often higher. Some NP Tg mice had very severe thyroid infl ammation, with proliferation of thyroid epithelial cells ( , do not secrete Ig, and presumably do not include specifi cities for thyroid proteins. This suggests that traffi cking of B cells to the thyroid can be independent of specifi city for thyroid proteins and/or secretion of autoantibodies, and production of autoantibodies in the thyroid or in the circulation is not necessary for optimal thyroid damage.
Depletion of CD25 + T cells does not result in SAT in other SAT-resistant NOD.H-2h4 mice
Because B cell-defi cient and NP Tg mice, both normally resistant to SAT, developed SAT after anti-CD25 treatment, it was of interest to determine if other SAT-resistant mice also developed SAT after depletion of CD25 + T cells. To address this question, IFN-γ-defi cient mice (24) and WT NOD.H2h4 mice that have mutated and do not develop SAT (25) were given three weekly injections of anti-CD25 beginning at 10 d of age and 0.05% NaI water at 8 wk. Thyroids were examined 8 wk later (Table III) . Anti-CD25 did not result in SAT in these mice, suggesting that their resistance to SAT is probably not due to T reg cell activity. More importantly, the results indicate that the transient lymphopenia induced by CD25 depletion (26-28) is not suffi cient for development of SAT. It is not known why SAT-resistant WT NOD.H-2h4 mice given anti-CD25 had higher anti-MTg autoantibody responses than controls (Table III) .
Timing of CD25 depletion is not critical for SAT development in B cell-defi cient or NP Tg mice
Our previous study suggested that B cells were required during the fi rst 4-6 wk after birth for development of SAT in WT mice (5) . To determine if early CD25 depletion was necessary for B cell-defi cient mice to develop SAT, B celldefi cient and NP Tg mice were given three weekly injections of anti-CD25 beginning 11 d, 4 wk, or 8 wk after birth (Table IV) . Mice given anti-CD25 11 d or 4 wk after birth all developed SAT with similar severity scores. Because CD25 depletion is transient ( Fig. 1 F) , normal numbers of CD25 + T cells were present when mice began NaI water. In preliminary experiments, B cell-defi cient mice given anti-CD25 beginning at 8 wk developed minimal SAT (not depicted), and NP Tg mice given anti-CD25 beginning at 8 wk developed 
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less severe SAT than those given anti-CD25 at day 11 (Table  IV , lines 6 and 7). Because mice all began NaI water at 8 wk of age, CD25 depletion was maintained during the fi rst 3 wk when eff ector T cell activation begins (1). Because activated eff ector CD4 + T cells also express CD25, it was important to determine if mice given anti-CD25 beginning at 8 wk of age would develop SAT if more time was allowed for optimal development of SAT. Therefore, mice given anti-CD25 at weeks 8, 9, and 10 were given NaI water at 11 wk of age, and thyroids were removed 8 wk later. Most mice developed SAT, although the severity scores were slightly lower than in mice given anti-CD25 earlier (Table IV , line 4 vs. lines 2 and 3). These results suggest that if suffi cient time is allowed for SAT development, eff ector T cell function can be manifest even when T reg cells are eliminated in adults.
T reg cells that inhibit SAT in B cell-defi cient and NP Tg mice are eliminated by day 3 Tx
Because naturally occurring T reg cells are eliminated by Tx at 3 d of age (21, 22, 29) , we asked if day 3 Tx B celldefi cient and NP Tg mice would develop SAT (7-9, 21, 22, 30) . Groups of WT and Tg mice were thymectomized at 3 d, given NaI water at 8 wk, and thyroids were removed 8 wk later (Table V) . Day 3 Tx had no eff ect on SAT development in WT mice. These results are consistent with those obtained using anti-CD25 ( Table I ) and suggest that T reg cells do not inhibit SAT in WT mice. However, most Tx NP Tg (Table V) and B cell-defi cient (not depicted) mice developed SAT, indicating that eff ector T cells can be activated and/or expanded when T reg cells are eliminated by day 3 Tx. The two NP Tg mice in Table V that did not develop SAT had thymic remnants at autopsy and were not lymphopenic. In contrast, all Tx WT mice and the six NP Tg mice that developed SAT had minimal or no residual thymus and were T cell lymphopenic, with a 30-50% reduction in CD4 + and CD8 + T cells in peripheral blood and spleen relative to non-Tx littermates and a correspondingly increased percentage of B220 + B cells (not depicted). 
cells (31-34).
To determine if diff erences in the numbers of CD4 + 25 + Foxp3 + cells might explain why WT mice are susceptible and B cell-defi cient mice are resistant to SAT, spleen cells from 6-8-wk-old WT and B cell-defi cient mice were separated into CD4 + CD25-depleted and CD4 + CD25-enriched populations as described in Materials and methods. RNA was isolated and reverse transcribed, and real-time PCR for Foxp3 was performed. CD4 + CD25 + cells from both WT and B cell-defi cient mice had a much higher expression of Foxp3 mRNA than CD25-depleted cells from the same mice (Fig. 4 A) , and CD25 + T cells in WT and B cell-defi cient mice expressed comparable levels of Foxp3. CD4 + splenic T cells from 8-wk-old WT and B cell-defi cient mice were also examined for Foxp3 expression by fl ow cytometry (Fig.  4 , B-D) and immunohistochemical staining (not depicted). These results also indicated that WT and B cell-defi cient mice have similar numbers of CD4 + CD25 + Foxp3 + T cells in spleens (Fig. 4 , B-D) and cervical lymph nodes (not depicted) at the time they begin NaI water. The percentages of CD4 + CD25 − Foxp3 + cells that may be able to diff erentiate into CD25 + T reg cells were also similar in the spleens of WT and B cell-defi cient mice (Fig. 4, C and D (Fig. 4 A) , and NP Tg mice (not depicted) highly expressed mRNA for Foxp3, a marker expressed by CD4 + CD25 + T cells with regulatory function but not by CD4 + CD25 + eff ector T cells (31) (32) (33) (34) . CD4 + CD25 + T cells from WT, NP Tg, and B cell-defi cient mice all had similar levels of Foxp3 mRNA (Fig. 4 A and not depicted) . Flow cytometry results also indicated that the spleens of WT and B cell-defi cient mice had similar numbers of CD4 + CD25 + Foxp3 + as well as CD4 + CD25 − Foxp3 + cells (Fig. 4, B-D 
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for the activation of autoreactive T cells (10, 11, (17) (18) (19) (20) , or that autoreactive T cells were activated in B cell-defi cient mice but did not induce tissue damage (11, 36) . Alard et al. (30) and Tung et al. (37) showed that T cells able to respond to an ovarian self-antigen were present in neonatal mice. Tolerance to the antigen developed in the fi rst week of life in females, but males that did not express the antigen did not develop tolerance. We previously hypothesized that B celldefi cient mice might not develop SAT if the antigen that initiates activation of autoreactive T cells for SAT had to be presented by B cells. In the absence of B cells, presentation of antigen by other APCs might induce unresponsiveness so autoreactive T cells would be unable to respond even if antigen-presenting B cells were subsequently provided. To test this hypothesis, we used B cell-defi cient mice to ask if SAT would develop if T reg cells were depleted. The results suggest that T reg cells may be preferentially activated in SATresistant B cell-defi cient NOD.H-2h4 mice. When T reg cells are depleted using anti-CD25 mAb or by day 3 Tx, effector T cells are activated and B cell-defi cient mice develop SAT (Tables I and IV) . Similar mechanisms are apparently operative in mice with Ig nonsecreting B cells specifi c for the NP hapten (Table II) .
To our knowledge, these results are the fi rst to demonstrate that resistance of B cell-defi cient mice to autoimmune diseases can be due to the activity of T reg cells. Consistent with our results, Olson et al. (38) recently showed that B cells expanding in mice developing intestinal infl ammation in a mouse model of Crohn's disease could block T reg cell activity, resulting in exacerbation of disease. B cells in their model expressed increased mRNA for GITR-L compared with B cells from control mice that did not block T reg cell activity. GITR-L, expressed by APCs including dendritic cells, B cells, and macrophages, interacts with GITR, a molecule expressed by both T reg and activated T eff ector cells (38) (39) (40) (41) (42) . When GITR is engaged with its ligand, suppression is presumably "off ," whereas when GITR and its ligand are not engaged, suppression is "on" (40) . Our results could be explained if B cells in WT NOD.H-2h4 mice expressed more GITR-L (or another molecule able to interfere with T reg cell activity) than B cells from NP Tg mice or non-B cell APCs in NP Tg or B cell-defi cient mice. Although further studies are needed to fully address this possibility, preliminary results indicate that splenocytes from WT, B cell-defi cient, and NP Tg mice express similar levels of GITR-L mRNA (not depicted).
Another unexpected and interesting observation in this study was that depletion of T reg cells in NP Tg mice resulted in very severe SAT with many B220 + B cells in thyroids (Fig. 3) . These results indicate that B cells can traffi c to sites of infl ammation even if they have no apparent specifi city for thyroid antigens and are unable to secrete autoantibodies. The role played by presumably antigen-nonspecifi c B cells in the thyroids of NP Tg mice is unknown, although they may be able to present thyroid antigens to eff ector T cells in sites where the antigen is abundant, as in the thyroid.
Antigen-nonspecifi c B cells also migrate to the pancreas in NP Tg B cell-defi cient nonobese diabetic (NOD) mice, but the incidence of diabetes was very low compared with that in WT NOD mice (43) . In a model of autoimmune arthritis with a requirement for B cells for development of disease, B cells from NP Tg mice functioned as APCs for activation of T cells only if autoantigen was specifi cally targeted to B cells to increase antigen uptake (20) . This suggests that conjugating MTg, the putative autoantigen for SAT, to NP might result in increased uptake of MTg by NP-specifi c B cells, and NP Tg mice might then develop SAT. Studies to address this possibility are in progress. In addition to the diff erence in antigen specifi cities of the B cells in NP Tg and WT mice, mice lacking serum IgM reportedly have more marginal zone B cells and fewer follicular B cells (44) , and diff erences in B cell subsets could also infl uence whether T reg or T eff ector cells would be preferentially activated.
Several studies have shown that CD4 + CD25 + T cells can regulate experimental autoimmune thyroiditis in mice (45) (46) (47) (48) (49) . In some cases, T reg cells were presumably induced by MTg presented peripherally on particular subsets of dendritic cells (47, 48) or by MTg presented under tolerogenic conditions (45) . In contrast, the T reg cells described here presumably belong to the class of "natural" T reg cells because their function is lost after day 3 Tx (21, 22) . These natural T reg cells might be activated by Tg expressed in the thymus during T cell development (50, 51) . Further studies will be required to determine if T reg cells that inhibit SAT in B celldefi cient and NP Tg mice are specifi cally activated by MTg or another thyroid antigen, and whether they are activated in the thymus or in peripheral lymphoid organs (52) .
MATERIALS AND METHODS
Mice.
NOD.H-2h4 mice, originally provided by L. Wicker (University of Cambridge, Cambridge, UK), are I-E negative and express I-A k , H-2K k , and D d on the NOD background (1-4) . B cell-defi cient NOD.H-2h4 mice were derived as described previously (5) . NOD mice expressing Tg B cells specifi c for the NP hapten and unable to secrete Ig (12, 43) were obtained from S. Wong (Yale University, New Haven, CT). They were crossed with B cell-defi cient NOD.H-2h4 mice to generate NP Tg mice on the NOD. H-2h4 B cell-defi cient background. The mice are serum Ig negative and have normal numbers of peripheral B220 + B cells that express the NP transgene (12, 20) . All mice were bred and maintained under specifi c pathogenfree conditions in our animal facilities at the University of Missouri. All animal protocols were approved by the University of Missouri and the VA Animal Care and Use Committees. Both male and female mice were used, and mice were age-and sex-matched for each experiment. All mice received 0.05% NaI in their drinking water beginning at 7-8 wk of age.
Antibody treatment, Tx, and experimental design. Mice were given 3 weekly 0.5-mg injections of rat anti-mouse CD25 mAb PC61 (American Type Culture Collection [ATCC]) beginning in most experiments 10-11 d after birth (23) . In some experiments, antibody treatments began later or mice were given rat anti-mouse IL-10 mAb JESS 2A5 (ATCC) as indicated in Results. Anti-CD25 and anti-IL-10 were purifi ed from cell culture supernatants using Protein G columns (Kierkegaard and Perry). At 8 wk of age, treated and control mice were given 0.05% NaI water and thyroids were removed 8-9 wk later (1, 5) . For some experiments, mice were thymectomized 3 d after birth as described previously (29) . In brief, 3-d-old mice were anesthetized on ice, chests were opened, and thymic lobes were removed by suction. Mice were given 0.05% NaI water at 8 wk of age, and thyroids were removed 8-9 wk later. At the time of thyroid removal, the thoracic cavity was carefully inspected and mice with obvious thymic remnants were excluded from the experiments.
Assessment of thyroiditis.
Thyroids were collected and one thyroid lobe from each mouse was fi xed in formalin, sectioned, and stained with hematoxylin and eosin as described previously (1, 5) . The other thyroid lobe from each mouse was snap frozen in liquid nitrogen and stored at −70°C for use in immunohistochemical staining. Thyroid histopathology was scored for the extent of thyroid follicle destruction using a scale of 0 to 5+ as described previously (1, 4, 5) . All slides were coded and read by two individuals, one of whom had no knowledge of the experimental groups. In brief, a score of 0 indicates a normal thyroid, and 0+ indicates a few infl ammatory cells infi ltrating the thyroids and/or mild follicular changes. A 1+ severity score is defi ned as an infi ltrate of at least 125 cells in one or several foci, and a 2+ score represents 10-20 foci of cellular infi ltration, each the size of several follicles, with destruction of up to one fourth of the gland. A 3+ score indicates that one fourth to one half of the thyroid follicles are destroyed or replaced by infi ltrating infl ammatory cells, whereas a 4+ score indicates that greater than one half of the gland is destroyed. A few thyroids had almost no remaining intact follicles, and these were given a score of 5+. As described previously (1), thyroid lesions in NOD.H-2h4 mice reach maximal severity 7-9 wk after mice are given NaI water beginning at 2 mo of age; lesions are chronic and remain relatively unchanged in severity for several months (1, 4) .
Autoantibody determination. MTg-specifi c autoantibodies were assessed by ELISA using serum from individual mice as described previously (1, 5) .
Flow cytometry. Spleen cells or PBLs were analyzed for expression of CD4, CD8 and CD25 by fl ow cytometry as described previously (5) . FITCconjugated antibodies were obtained from Caltag Laboratories. PE-conjugated anti-CD25 was obtained from SouthernBiotech (7D4) or Caltag Laboratories (PC 61). Flow cytometry for Foxp3 was performed using splenocytes from 8-wk-old NOD.H-2h4 WT or B cell-defi cient mice using a Foxp3 staining kit according to the manufacturer's protocol (eBioscience). Antibodies used were FITC-conjugated anti-CD4 (Caltag Laboratories), PECy5-conjugated CD25 (eBioscience), and PE-conjugated Foxp3 (eBioscience). Cells were analyzed using a FACScan (BD Biosciences).
Separation of CD4 + CD25 + and CD4 + CD25-depleted splenocytes. Spleen cells from 6-8-wk-old naive WT and B cell-defi cient mice were separated into CD4 + CD25 + and CD4 + CD25-depleted populations as follows. Mice were given anti-CD8 mAb 3 d before use to deplete splenic CD8 + T cells. Spleen cells were depleted of most B cells and macrophages by passage over nylon wool columns. Nylon wool nonadherent WT cells typically expressed no detectable CD8 + T cells and <15% B cells, and cells from B cell-defi cient mice were >90% CD4 + when analyzed by fl ow cytometry. CD4 + CD25 + cells were positively selected by labeling with PEconjugated PC61 and separated into CD25 + and CD25-depleted populations using Easy Sep magnetic beads (StemCell Technologies Inc.). Cells recovered in the CD25 + fraction comprised <10% of the total CD4 + T cells, and ‫%58ف‬ were CD4 + CD25 + as determined by fl ow cytometry. The CD25-depleted population comprised >90% of the CD4 + T cells and always had some residual CD25 + CD4 + cells as determined by fl ow cytometry. Cells were counted, pelleted, and snap frozen in liquid nitrogen at 2-4 × 10 6 cells per tube.
Quantitative PCR. RNA was isolated using TRIzol (Invitrogen) and cDNA was synthesized as described previously in detail (1) . Quantitative PCR was performed using ABsolute QPCR SYBR Green ROX Mix (ABgene) in an ABI PRISM 7000 sequence detection system (Applied Biosystems). A series of fi ve standards with defi ned values was included in each reaction and a standard curve was obtained to calculate the amount of gene amplifi ed. A dissociation curve was generated to verify the amplifi cation of a single product. The primer sequences for Foxp3 and the housekeeping gene HPRT were described previously (1, 53) . The level of HPRT expression for each sample was used for data normalization.
Immunohistochemical staining. Immunohistochemical staining of frozen thyroid sections was performed as described previously (4, 24) using the following primary antibodies: anti-CD4 (GK 1.5; ATCC), anti-CD8 (53.67; ATCC), anti-CD11b (CRL 1969; ATCC), or anti-B220 (Caltag Laboratories). Biotinylated goat anti-rat IgG (Caltag Laboratories) was used as secondary antibody, and 0.3% hydrogen peroxide was used to block endogenous peroxidase. Sections were incubated with Vectastain Elite ABC kit (Vector Laboratories), and peroxidase activity was visualized using the Nova-Red substrate (Vector Laboratories). Slides were counterstained with hematoxylin. Negative controls used IgG isotype controls as primary antibody, with the remaining steps performed as described above. These controls were always negative.
Student's t test. Statistical analysis was performed using an unpaired twotailed Student's t test. A value of P < 0.05 was considered statistically signifi cant.
